Safety Reporting & Signal Detection
Comprehensive safety reporting tailored to your needs
Safety reporting is a critical component of pharmacovigilance and post-marketing surveillance. At QbD Group, we analyze and deliver safety reports that ensure compliance with global regulatory requirements.
What is safety reporting?
Safety reporting involves the periodic collection, analysis, and submission of safety data from multiple sources. These reports provide a holistic view of a product's safety profile and are essential for ongoing regulatory compliance and risk mitigation.
Key types of safety reports:
- IND Annual Reports: Documenting safety information from clinical trials for investigational drugs.
- Clinical Study Reports (CSRs): Comprehensive summaries of clinical trial data.
- New Drug Applications (NDAs): Safety data submitted for regulatory approval of new drugs.
- Periodic Safety Update Reports (PSURs) / Periodic Benefit-Risk Evaluation Reports (PBRERs): Post-marketing safety evaluations.
- Development Safety Update Reports (DSURs): Ongoing assessments during clinical development.
- Signal detection: Comprehensive signal management — from data collection to regulatory reporting — delivering actionable insights for proactive risk mitigation.
Why is safety reporting essential?
Regulatory adherence
Meet global reporting requirements and avoid penalties or delays.
Risk management
Identify and address emerging safety signals early.
Product confidence
Provide stakeholders with clear evidence of a product's safety and efficacy.
Streamlined processes
Efficiently manage and submit comprehensive safety data.
Timely risk identification
Early detection of potential safety issues prevents escalation and reduces harm.
How can we help?
QbD Group's safety reporting services leverage advanced methodologies, including the PSO/ACO classification approach, to deliver precise and actionable insights:
Report compilation and delivery
IND Annual Reports, CSRs, NDAs, PSURs/PBRERs, and DSURs tailored to meet your regulatory needs.
Advanced methodologies
Utilizing PSO/ACO for classification and rule discovery to optimize post-marketing surveillance.
Regulatory expertise
Ensure alignment with EMA, FDA, and other global authorities.
Comprehensive solutions
From data analysis to report submission, we manage the entire process.
Custom workflows
Tailored reporting strategies that align with your operational goals.
Expert risk management
Evaluating and classifying signals to determine their clinical significance.
Why QbD Group
Your trusted partner
Choosing QbD Group for safety reporting ensures:
Expert knowledge
decades of experience in pharmacovigilance and regulatory compliance.
Innovative approaches
advanced methodologies like PSO/ACO for superior safety data analysis.
Seamless service
end-to-end support from data collection to regulatory submission.
Proven track record
successful delivery of safety reports for a wide range of products and markets.
Let's talk Pharmacovigilance
From QPPV services to signal management, our safety experts are ready to support your pharmacovigilance needs.